Skip to main content
. 2021 May 28;77(4):800–806. doi: 10.1093/gerona/glab150

Table 1.

Participants’ Characteristics and Neuroimaging Markers of Interest at the Time of Brain MRI and Their Bivariate Associations With the Slope of Energy and Mild Parkinsonian Signs (n = 293)

Mean (SD) Are Reported Unless Otherwise Noted Correlations With SEL Slopes, r (p value) or Mean Difference ± SD (p value) Correlations With MPS, Mean Difference ± SD (p value), Chi square or t Test p-value, or r (p Value)
Demographics
 Age, y 83.0 (2.8) −0.029 (.620) 1.2 ± 2.8 (<.001)
 Women, N (%) 171 (58) −0.006 ± 0.05 (.318) 0.999
 Black, N (%) 114 (39) 0.010 ± 0.05 (.069) 0.630
 Postsecondary education 151 (52) −0.002 ± 0.05 (.684) 0.195
 Body mass index, kg/m2 27.4 (4.4) −0.090 (.124) 0.6 ± 4.4 (.280)
Energy
 Baseline SEL at Year 2 6.8 (1.5) 0.049 (.399) −0.2 ± 1.5 (.260)
 SEL slopes, change per year −0.06 (0.05) −0.019 ± 0.049 (.001)
Mobility performance at Year 1
 Short Physical Performance Battery (0–12) 10.4 (1.3) 0.224 (<.001) −0.48 ± 1.23 (.001)
 Chair stand per second 0.39 (0.11) 0.194 (<.001) −0.05 ± 0.11 (<.001)
 Gait speed over 3, 4, or 6 m, m/s 1.27 (0.24) 0.118 (.043) −0.07 ± 0.24 (.012)
 Standing balance, s (0–90) 72.9 (20.8) 0.119 (.042) −6.6 ± 20.6 (.008)
Mild parkinsonian signs (UPDRS ≥ 1), N (%) 128 (44) −0.019 ± 0.049 (.001)
Fatigue, N (%) 85 (29) −0.030 ± 0.048 (<.001) 0.027
Prevalence of cardiovascular disease 84 (29) −0.005 ± 0.050 (.405) 0.364
Prevalence of stroke 24 (8) −0.005 ± 0.050 (.648) 0.391
Prevalence of diabetes 74 (25) −0.017 ± 0.050 (.014) 0.685
Prevalence of myocardial infarction 49 (17) −0.011 ± 0.050 (.164) 0.999
Normalized white matter hyperintensities 0.0058 (0.0074) −0.018 (.760) 0.002 ± 0.007 (.007)
Striatum, cm3 11.6 (3.7) 0.112 (.056) −0.005 (.927)
 Left striatum 5.5 (2.0) 0.073 (.217) −0.015 (.800)
 Right striatum 6.1 (1.9) 0.140 (.017) 0.005 (.937)
Globus pallidus, cm3 0.53 (0.49) 0.040 (.498) 0.018 (.757)
 Left pallidus 0.25 (0.24) 0.024 (.680) 0.007 (.902)
 Right pallidus 0.29 (0.28) 0.049 (.401) 0.026 (.660)
Thalamus, cm3 1.8 (0.4) −0.046 (.438) −0.002 (.970)
 Left thalamus 0.91 (0.23) −0.052 (.380) −0.026 (.657)
 Right thalamus 0.93 (0.24) −0.035 (.555) 0.021 (.727)
Primary motor cortex, cm3 16.8 (2.7) 0.054 (.357) −0.183 (.002)
 Left precentral gyrus 8.8 (1.5) 0.002 (.974) −0.165 (.005)
 Right precentral gyrus 8.1 (1.4) 0.099 (.090) −0.169 (.004)
Primary sensory cortex, cm3 19.1 (3.2) 0.084 (.150) −0.161 (.006)
 Left postcentral gyrus 10.0 (1.8) 0.080 (.171) −0.151 (.010)
 Right postcentral gyrus 9.1 (1.7) 0.074 (.203) −0.145 (.013)
Limbic area, cm3 29.3 (3.9) −0.009 (.877) −0.065 (.265)
 Left limbic area 14.5 (2.1) 0.016 (.783) −0.055 (.347)
 Right limbic area 14.8 (2.0) −0.034 (.568) −0.068 (.245)
Dorsolateral prefrontal cortex, cm3 2.7 (3.2) 0.012 (.832) −0.123 (.036)
 Left middle frontal gyrus 13.2 (1.7) 0.013 (.823) 0.114 (.053)
 Right middle frontal gyrus 13.8 (1.8) 0.009 (.873) 0.108 (.066)

Notes: MPS = mild parkinsonian signs; SEL = self-reported energy level; UPDRS = Unified Parkinson Disease Rating Scale. Correlations with regional neuroimaging markers were adjusted for normalized total gray matter volume, ie, ratio of total gray matter volume by intracranial volume. The bold number reflects correlations at p <.05. Normalized white matter hyperintensities: ratio of total white matter hyperintensities by total brain volume.